Inato
Paris
About Inato
Inato automates data structuring and analysis, cross-checks data sources, and provides insights on this data. It features a tool for collecting and analyzing data used in clinical trials, Inato’s AI-powered platform enables pharmaceutical companies to drastically reduce drug development costs. By accelerating clinical trials, Inato helps new therapies arrive to patients faster, and at lower prices
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $35.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2023)
- Website: inato.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Clinical Trials, Health Care, Machine Learning, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/inato-58799 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.